Cevatemre, B. Et Al. 2018. A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer. PHARMACOLOGICAL RESEARCH , vol.129 , 500-514.

Cevatemre, B., Erkisa, M., Aztopal, N., Karakas, D., Alper, P., Tsimplouli, C., ... Sereti, E.(2018). A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer. PHARMACOLOGICAL RESEARCH , vol.129, 500-514.

Cevatemre, Buse Et Al. "A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer," PHARMACOLOGICAL RESEARCH , vol.129, 500-514, 2018

Cevatemre, Buse Et Al. "A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer." PHARMACOLOGICAL RESEARCH , vol.129, pp.500-514, 2018

Cevatemre, B. Et Al. (2018) . "A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer." PHARMACOLOGICAL RESEARCH , vol.129, pp.500-514.

@article{article, author={Buse Cevatemre Et Al. }, title={A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer}, journal={PHARMACOLOGICAL RESEARCH}, year=2018, pages={500-514} }